Martin A Walter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Martin A Walter

Showing results (61-70 of 78) with videos related to

Pageof 8

Sort By:

Endocrine-Related Cancer|December 13, 2018

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort studyEsben Andreas Carlsen, Nicola Fazio, Dan Granberg, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020

Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysisChristian Mirian, Anne Katrine Duun-Henriksen, Andrea Maier, et al.

European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.

European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2021

The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.

Neurosurgical Review|August 19, 2022

Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.

The Journal of Clinical Endocrinology and Metabolism|April 2, 2009

Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2Carsten C Boedeker, Zoran Erlic, Stéphane Richard, et al.

JAMA|October 27, 2005

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC geneFrancesca Schiavi, Carsten C Boedeker, Birke Bausch, et al.

BMC Medical Research Methodology|August 30, 2012

Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)Benjamin Kasenda, Erik B von Elm, John You, et al.

The Journal of Clinical Endocrinology and Metabolism|April 12, 2007

Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.

BMJ (Clinical Research Ed.)|July 18, 2014

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publicationsBenjamin Kasenda, Stefan Schandelmaier, Xin Sun, et al.

Pageof 8

Search research articles

Showing results (61-70 of 78) with videos related to

Sort By:

Pageof 8

Endocrine-Related Cancer|December 13, 2018

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort studyEsben Andreas Carlsen, Nicola Fazio, Dan Granberg, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020

Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysisChristian Mirian, Anne Katrine Duun-Henriksen, Andrea Maier, et al.

European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.

European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2021

The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.

Neurosurgical Review|August 19, 2022

Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.

The Journal of Clinical Endocrinology and Metabolism|April 2, 2009

Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2Carsten C Boedeker, Zoran Erlic, Stéphane Richard, et al.

JAMA|October 27, 2005

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC geneFrancesca Schiavi, Carsten C Boedeker, Birke Bausch, et al.

BMC Medical Research Methodology|August 30, 2012

Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)Benjamin Kasenda, Erik B von Elm, John You, et al.

The Journal of Clinical Endocrinology and Metabolism|April 12, 2007

Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.

BMJ (Clinical Research Ed.)|July 18, 2014

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publicationsBenjamin Kasenda, Stefan Schandelmaier, Xin Sun, et al.

Pageof 8